Global Mesylate Safinamide Market Growth 2026-2032
The global Mesylate Safinamide market size is predicted to grow from US$ 548 million in 2025 to US$ 1452 million in 2032; it is expected to grow at a CAGR of 16.0% from 2026 to 2032.
In 2025, global safinamide mesylate tablet production reached approximately 321,700 units.Safinamide is a medication used to treat Parkinson's disease, primarily working by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release. It helps regulate the dopamine system in the brain, alleviating motor symptoms in Parkinson's disease patients, such as tremors, rigidity, and bradykinesia. Safinamide is often used in combination with levodopa to enhance treatment efficacy, particularly when the effects of levodopa diminish. The medication is typically available in oral tablet form, and patients use it according to their doctor's guidance. During treatment, safinamide can significantly improve the patient's quality of life and reduce symptom fluctuations.
Safinamide holds an important position in the global Parkinson's disease treatment market, especially in improving motor symptoms in Parkinson's disease patients. With the aging population increasing, the number of Parkinson's disease patients globally continues to rise, providing a broad market demand for Safinamide. This drug works by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release, alleviating symptoms in Parkinson's disease patients. When used in combination with levodopa, it significantly improves treatment outcomes and enhances the quality of life for patients. The market prospects for Safinamide are driven by several factors. Firstly, with the increase in early diagnosis of Parkinson's disease, the demand for effective medications among patients is growing. Secondly, Safinamide has strong competitiveness in the market, particularly among levodopa-resistant patient populations, where its use is gradually being recognized. However, there is still competition from other drugs such as dopamine agonists and anticholinergic medications, which results in a competitive market environment.
LP Information, Inc. (LPI) ' newest research report, the ?Mesylate Safinamide Industry Forecast? looks at past sales and reviews total world Mesylate Safinamide sales in 2025, providing a comprehensive analysis by region and market sector of projected Mesylate Safinamide sales for 2026 through 2032. With Mesylate Safinamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesylate Safinamide industry.
This Insight Report provides a comprehensive analysis of the global Mesylate Safinamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesylate Safinamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mesylate Safinamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesylate Safinamide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesylate Safinamide.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesylate Safinamide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mesylate Safinamide market?
What factors are driving Mesylate Safinamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesylate Safinamide market opportunities vary by end market size?
How does Mesylate Safinamide break out by Type, by Application?
In 2025, global safinamide mesylate tablet production reached approximately 321,700 units.Safinamide is a medication used to treat Parkinson's disease, primarily working by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release. It helps regulate the dopamine system in the brain, alleviating motor symptoms in Parkinson's disease patients, such as tremors, rigidity, and bradykinesia. Safinamide is often used in combination with levodopa to enhance treatment efficacy, particularly when the effects of levodopa diminish. The medication is typically available in oral tablet form, and patients use it according to their doctor's guidance. During treatment, safinamide can significantly improve the patient's quality of life and reduce symptom fluctuations.
Safinamide holds an important position in the global Parkinson's disease treatment market, especially in improving motor symptoms in Parkinson's disease patients. With the aging population increasing, the number of Parkinson's disease patients globally continues to rise, providing a broad market demand for Safinamide. This drug works by inhibiting monoamine oxidase B (MAO-B) and enhancing dopamine release, alleviating symptoms in Parkinson's disease patients. When used in combination with levodopa, it significantly improves treatment outcomes and enhances the quality of life for patients. The market prospects for Safinamide are driven by several factors. Firstly, with the increase in early diagnosis of Parkinson's disease, the demand for effective medications among patients is growing. Secondly, Safinamide has strong competitiveness in the market, particularly among levodopa-resistant patient populations, where its use is gradually being recognized. However, there is still competition from other drugs such as dopamine agonists and anticholinergic medications, which results in a competitive market environment.
LP Information, Inc. (LPI) ' newest research report, the ?Mesylate Safinamide Industry Forecast? looks at past sales and reviews total world Mesylate Safinamide sales in 2025, providing a comprehensive analysis by region and market sector of projected Mesylate Safinamide sales for 2026 through 2032. With Mesylate Safinamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesylate Safinamide industry.
This Insight Report provides a comprehensive analysis of the global Mesylate Safinamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesylate Safinamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mesylate Safinamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesylate Safinamide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesylate Safinamide.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesylate Safinamide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Hospitals
- Retail
- Online
- Safinamide Mesylate in combination with Dopamine Receptor Agonists
- Safinamide Mesylate in combination with Levodopa
- Oral
- Injectable
- Innovator
- Generic
- Used in combination with Levodopa
- Treatment of Levodopa-resistant Parkinson's Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zambon S.p.A.
- Polpharma
- Biophore India Pharmaceuticals Pvt Ltd
- LGM Pharma
- Metrochem API Private Limited
- Cohance Lifesciences
- Zhejiang Hengkang Pharmaceutical
- HRV Pharma
- Honour Lab Limited
What is the 10-year outlook for the global Mesylate Safinamide market?
What factors are driving Mesylate Safinamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesylate Safinamide market opportunities vary by end market size?
How does Mesylate Safinamide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesylate Safinamide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mesylate Safinamide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mesylate Safinamide by Country/Region, 2021, 2025 & 2032
2.2 Mesylate Safinamide Segment by Type
2.2.1 Hospitals
2.2.2 Retail
2.2.3 Online
2.2.4 Mesylate Safinamide Sales by Type
2.2.4.1 Global Mesylate Safinamide Sales Market Share by Type (2021-2026)
2.2.4.2 Global Mesylate Safinamide Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Mesylate Safinamide Sale Price by Type (2021-2026)
2.3 Mesylate Safinamide Segment by Combination Therapy
2.3.1 Safinamide Mesylate in combination with Dopamine Receptor Agonists
2.3.2 Safinamide Mesylate in combination with Levodopa
2.3.3 Mesylate Safinamide Sales by Combination Therapy
2.3.3.1 Global Mesylate Safinamide Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Mesylate Safinamide Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Mesylate Safinamide Sale Price by Combination Therapy (2021-2026)
2.4 Mesylate Safinamide Segment by Dosage Form
2.4.1 Oral
2.4.2 Injectable
2.4.3 Mesylate Safinamide Sales by Dosage Form
2.4.3.1 Global Mesylate Safinamide Sales Market Share by Dosage Form (2021-2026)
2.4.3.2 Global Mesylate Safinamide Revenue and Market Share by Dosage Form (2021-2026)
2.4.3.3 Global Mesylate Safinamide Sale Price by Dosage Form (2021-2026)
2.5 Mesylate Safinamide Segment by Manufacturing Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Mesylate Safinamide Sales by Manufacturing Technology
2.5.3.1 Global Mesylate Safinamide Sales Market Share by Manufacturing Technology (2021-2026)
2.5.3.2 Global Mesylate Safinamide Revenue and Market Share by Manufacturing Technology (2021-2026)
2.5.3.3 Global Mesylate Safinamide Sale Price by Manufacturing Technology (2021-2026)
2.6 Mesylate Safinamide Segment by Application
2.6.1 Used in combination with Levodopa
2.6.2 Treatment of Levodopa-resistant Parkinson's Disease
2.6.3 Others
2.6.4 Mesylate Safinamide Sales by Application
2.6.4.1 Global Mesylate Safinamide Sale Market Share by Application (2021-2026)
2.6.4.2 Global Mesylate Safinamide Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Mesylate Safinamide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mesylate Safinamide Breakdown Data by Company
3.1.1 Global Mesylate Safinamide Annual Sales by Company (2021-2026)
3.1.2 Global Mesylate Safinamide Sales Market Share by Company (2021-2026)
3.2 Global Mesylate Safinamide Annual Revenue by Company (2021-2026)
3.2.1 Global Mesylate Safinamide Revenue by Company (2021-2026)
3.2.2 Global Mesylate Safinamide Revenue Market Share by Company (2021-2026)
3.3 Global Mesylate Safinamide Sale Price by Company
3.4 Key Manufacturers Mesylate Safinamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesylate Safinamide Product Location Distribution
3.4.2 Players Mesylate Safinamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESYLATE SAFINAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Mesylate Safinamide Market Size by Geographic Region (2021-2026)
4.1.1 Global Mesylate Safinamide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mesylate Safinamide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mesylate Safinamide Market Size by Country/Region (2021-2026)
4.2.1 Global Mesylate Safinamide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mesylate Safinamide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mesylate Safinamide Sales Growth
4.4 APAC Mesylate Safinamide Sales Growth
4.5 Europe Mesylate Safinamide Sales Growth
4.6 Middle East & Africa Mesylate Safinamide Sales Growth
5 AMERICAS
5.1 Americas Mesylate Safinamide Sales by Country
5.1.1 Americas Mesylate Safinamide Sales by Country (2021-2026)
5.1.2 Americas Mesylate Safinamide Revenue by Country (2021-2026)
5.2 Americas Mesylate Safinamide Sales by Type (2021-2026)
5.3 Americas Mesylate Safinamide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesylate Safinamide Sales by Region
6.1.1 APAC Mesylate Safinamide Sales by Region (2021-2026)
6.1.2 APAC Mesylate Safinamide Revenue by Region (2021-2026)
6.2 APAC Mesylate Safinamide Sales by Type (2021-2026)
6.3 APAC Mesylate Safinamide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesylate Safinamide by Country
7.1.1 Europe Mesylate Safinamide Sales by Country (2021-2026)
7.1.2 Europe Mesylate Safinamide Revenue by Country (2021-2026)
7.2 Europe Mesylate Safinamide Sales by Type (2021-2026)
7.3 Europe Mesylate Safinamide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesylate Safinamide by Country
8.1.1 Middle East & Africa Mesylate Safinamide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mesylate Safinamide Revenue by Country (2021-2026)
8.2 Middle East & Africa Mesylate Safinamide Sales by Type (2021-2026)
8.3 Middle East & Africa Mesylate Safinamide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesylate Safinamide
10.3 Manufacturing Process Analysis of Mesylate Safinamide
10.4 Industry Chain Structure of Mesylate Safinamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesylate Safinamide Distributors
11.3 Mesylate Safinamide Customer
12 WORLD FORECAST REVIEW FOR MESYLATE SAFINAMIDE BY GEOGRAPHIC REGION
12.1 Global Mesylate Safinamide Market Size Forecast by Region
12.1.1 Global Mesylate Safinamide Forecast by Region (2027-2032)
12.1.2 Global Mesylate Safinamide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mesylate Safinamide Forecast by Type (2027-2032)
12.7 Global Mesylate Safinamide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zambon S.p.A.
13.1.1 Zambon S.p.A. Company Information
13.1.2 Zambon S.p.A. Mesylate Safinamide Product Portfolios and Specifications
13.1.3 Zambon S.p.A. Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zambon S.p.A. Main Business Overview
13.1.5 Zambon S.p.A. Latest Developments
13.2 Polpharma
13.2.1 Polpharma Company Information
13.2.2 Polpharma Mesylate Safinamide Product Portfolios and Specifications
13.2.3 Polpharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Polpharma Main Business Overview
13.2.5 Polpharma Latest Developments
13.3 Biophore India Pharmaceuticals Pvt Ltd
13.3.1 Biophore India Pharmaceuticals Pvt Ltd Company Information
13.3.2 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product Portfolios and Specifications
13.3.3 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biophore India Pharmaceuticals Pvt Ltd Main Business Overview
13.3.5 Biophore India Pharmaceuticals Pvt Ltd Latest Developments
13.4 LGM Pharma
13.4.1 LGM Pharma Company Information
13.4.2 LGM Pharma Mesylate Safinamide Product Portfolios and Specifications
13.4.3 LGM Pharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 LGM Pharma Main Business Overview
13.4.5 LGM Pharma Latest Developments
13.5 Metrochem API Private Limited
13.5.1 Metrochem API Private Limited Company Information
13.5.2 Metrochem API Private Limited Mesylate Safinamide Product Portfolios and Specifications
13.5.3 Metrochem API Private Limited Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Metrochem API Private Limited Main Business Overview
13.5.5 Metrochem API Private Limited Latest Developments
13.6 Cohance Lifesciences
13.6.1 Cohance Lifesciences Company Information
13.6.2 Cohance Lifesciences Mesylate Safinamide Product Portfolios and Specifications
13.6.3 Cohance Lifesciences Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cohance Lifesciences Main Business Overview
13.6.5 Cohance Lifesciences Latest Developments
13.7 Zhejiang Hengkang Pharmaceutical
13.7.1 Zhejiang Hengkang Pharmaceutical Company Information
13.7.2 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product Portfolios and Specifications
13.7.3 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.8 HRV Pharma
13.8.1 HRV Pharma Company Information
13.8.2 HRV Pharma Mesylate Safinamide Product Portfolios and Specifications
13.8.3 HRV Pharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 HRV Pharma Main Business Overview
13.8.5 HRV Pharma Latest Developments
13.9 Honour Lab Limited
13.9.1 Honour Lab Limited Company Information
13.9.2 Honour Lab Limited Mesylate Safinamide Product Portfolios and Specifications
13.9.3 Honour Lab Limited Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Honour Lab Limited Main Business Overview
13.9.5 Honour Lab Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesylate Safinamide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mesylate Safinamide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mesylate Safinamide by Country/Region, 2021, 2025 & 2032
2.2 Mesylate Safinamide Segment by Type
2.2.1 Hospitals
2.2.2 Retail
2.2.3 Online
2.2.4 Mesylate Safinamide Sales by Type
2.2.4.1 Global Mesylate Safinamide Sales Market Share by Type (2021-2026)
2.2.4.2 Global Mesylate Safinamide Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Mesylate Safinamide Sale Price by Type (2021-2026)
2.3 Mesylate Safinamide Segment by Combination Therapy
2.3.1 Safinamide Mesylate in combination with Dopamine Receptor Agonists
2.3.2 Safinamide Mesylate in combination with Levodopa
2.3.3 Mesylate Safinamide Sales by Combination Therapy
2.3.3.1 Global Mesylate Safinamide Sales Market Share by Combination Therapy (2021-2026)
2.3.3.2 Global Mesylate Safinamide Revenue and Market Share by Combination Therapy (2021-2026)
2.3.3.3 Global Mesylate Safinamide Sale Price by Combination Therapy (2021-2026)
2.4 Mesylate Safinamide Segment by Dosage Form
2.4.1 Oral
2.4.2 Injectable
2.4.3 Mesylate Safinamide Sales by Dosage Form
2.4.3.1 Global Mesylate Safinamide Sales Market Share by Dosage Form (2021-2026)
2.4.3.2 Global Mesylate Safinamide Revenue and Market Share by Dosage Form (2021-2026)
2.4.3.3 Global Mesylate Safinamide Sale Price by Dosage Form (2021-2026)
2.5 Mesylate Safinamide Segment by Manufacturing Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Mesylate Safinamide Sales by Manufacturing Technology
2.5.3.1 Global Mesylate Safinamide Sales Market Share by Manufacturing Technology (2021-2026)
2.5.3.2 Global Mesylate Safinamide Revenue and Market Share by Manufacturing Technology (2021-2026)
2.5.3.3 Global Mesylate Safinamide Sale Price by Manufacturing Technology (2021-2026)
2.6 Mesylate Safinamide Segment by Application
2.6.1 Used in combination with Levodopa
2.6.2 Treatment of Levodopa-resistant Parkinson's Disease
2.6.3 Others
2.6.4 Mesylate Safinamide Sales by Application
2.6.4.1 Global Mesylate Safinamide Sale Market Share by Application (2021-2026)
2.6.4.2 Global Mesylate Safinamide Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Mesylate Safinamide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mesylate Safinamide Breakdown Data by Company
3.1.1 Global Mesylate Safinamide Annual Sales by Company (2021-2026)
3.1.2 Global Mesylate Safinamide Sales Market Share by Company (2021-2026)
3.2 Global Mesylate Safinamide Annual Revenue by Company (2021-2026)
3.2.1 Global Mesylate Safinamide Revenue by Company (2021-2026)
3.2.2 Global Mesylate Safinamide Revenue Market Share by Company (2021-2026)
3.3 Global Mesylate Safinamide Sale Price by Company
3.4 Key Manufacturers Mesylate Safinamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesylate Safinamide Product Location Distribution
3.4.2 Players Mesylate Safinamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MESYLATE SAFINAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Mesylate Safinamide Market Size by Geographic Region (2021-2026)
4.1.1 Global Mesylate Safinamide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mesylate Safinamide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mesylate Safinamide Market Size by Country/Region (2021-2026)
4.2.1 Global Mesylate Safinamide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mesylate Safinamide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mesylate Safinamide Sales Growth
4.4 APAC Mesylate Safinamide Sales Growth
4.5 Europe Mesylate Safinamide Sales Growth
4.6 Middle East & Africa Mesylate Safinamide Sales Growth
5 AMERICAS
5.1 Americas Mesylate Safinamide Sales by Country
5.1.1 Americas Mesylate Safinamide Sales by Country (2021-2026)
5.1.2 Americas Mesylate Safinamide Revenue by Country (2021-2026)
5.2 Americas Mesylate Safinamide Sales by Type (2021-2026)
5.3 Americas Mesylate Safinamide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesylate Safinamide Sales by Region
6.1.1 APAC Mesylate Safinamide Sales by Region (2021-2026)
6.1.2 APAC Mesylate Safinamide Revenue by Region (2021-2026)
6.2 APAC Mesylate Safinamide Sales by Type (2021-2026)
6.3 APAC Mesylate Safinamide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesylate Safinamide by Country
7.1.1 Europe Mesylate Safinamide Sales by Country (2021-2026)
7.1.2 Europe Mesylate Safinamide Revenue by Country (2021-2026)
7.2 Europe Mesylate Safinamide Sales by Type (2021-2026)
7.3 Europe Mesylate Safinamide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesylate Safinamide by Country
8.1.1 Middle East & Africa Mesylate Safinamide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mesylate Safinamide Revenue by Country (2021-2026)
8.2 Middle East & Africa Mesylate Safinamide Sales by Type (2021-2026)
8.3 Middle East & Africa Mesylate Safinamide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesylate Safinamide
10.3 Manufacturing Process Analysis of Mesylate Safinamide
10.4 Industry Chain Structure of Mesylate Safinamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesylate Safinamide Distributors
11.3 Mesylate Safinamide Customer
12 WORLD FORECAST REVIEW FOR MESYLATE SAFINAMIDE BY GEOGRAPHIC REGION
12.1 Global Mesylate Safinamide Market Size Forecast by Region
12.1.1 Global Mesylate Safinamide Forecast by Region (2027-2032)
12.1.2 Global Mesylate Safinamide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mesylate Safinamide Forecast by Type (2027-2032)
12.7 Global Mesylate Safinamide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zambon S.p.A.
13.1.1 Zambon S.p.A. Company Information
13.1.2 Zambon S.p.A. Mesylate Safinamide Product Portfolios and Specifications
13.1.3 Zambon S.p.A. Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zambon S.p.A. Main Business Overview
13.1.5 Zambon S.p.A. Latest Developments
13.2 Polpharma
13.2.1 Polpharma Company Information
13.2.2 Polpharma Mesylate Safinamide Product Portfolios and Specifications
13.2.3 Polpharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Polpharma Main Business Overview
13.2.5 Polpharma Latest Developments
13.3 Biophore India Pharmaceuticals Pvt Ltd
13.3.1 Biophore India Pharmaceuticals Pvt Ltd Company Information
13.3.2 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product Portfolios and Specifications
13.3.3 Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biophore India Pharmaceuticals Pvt Ltd Main Business Overview
13.3.5 Biophore India Pharmaceuticals Pvt Ltd Latest Developments
13.4 LGM Pharma
13.4.1 LGM Pharma Company Information
13.4.2 LGM Pharma Mesylate Safinamide Product Portfolios and Specifications
13.4.3 LGM Pharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 LGM Pharma Main Business Overview
13.4.5 LGM Pharma Latest Developments
13.5 Metrochem API Private Limited
13.5.1 Metrochem API Private Limited Company Information
13.5.2 Metrochem API Private Limited Mesylate Safinamide Product Portfolios and Specifications
13.5.3 Metrochem API Private Limited Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Metrochem API Private Limited Main Business Overview
13.5.5 Metrochem API Private Limited Latest Developments
13.6 Cohance Lifesciences
13.6.1 Cohance Lifesciences Company Information
13.6.2 Cohance Lifesciences Mesylate Safinamide Product Portfolios and Specifications
13.6.3 Cohance Lifesciences Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Cohance Lifesciences Main Business Overview
13.6.5 Cohance Lifesciences Latest Developments
13.7 Zhejiang Hengkang Pharmaceutical
13.7.1 Zhejiang Hengkang Pharmaceutical Company Information
13.7.2 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product Portfolios and Specifications
13.7.3 Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Zhejiang Hengkang Pharmaceutical Main Business Overview
13.7.5 Zhejiang Hengkang Pharmaceutical Latest Developments
13.8 HRV Pharma
13.8.1 HRV Pharma Company Information
13.8.2 HRV Pharma Mesylate Safinamide Product Portfolios and Specifications
13.8.3 HRV Pharma Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 HRV Pharma Main Business Overview
13.8.5 HRV Pharma Latest Developments
13.9 Honour Lab Limited
13.9.1 Honour Lab Limited Company Information
13.9.2 Honour Lab Limited Mesylate Safinamide Product Portfolios and Specifications
13.9.3 Honour Lab Limited Mesylate Safinamide Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Honour Lab Limited Main Business Overview
13.9.5 Honour Lab Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mesylate Safinamide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mesylate Safinamide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hospitals
Table 4. Major Players of Retail
Table 5. Major Players of Online
Table 6. Global Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 7. Global Mesylate Safinamide Sales Market Share by Type (2021-2026)
Table 8. Global Mesylate Safinamide Revenue by Type (2021-2026) & ($ million)
Table 9. Global Mesylate Safinamide Revenue Market Share by Type (2021-2026)
Table 10. Global Mesylate Safinamide Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Safinamide Mesylate in combination with Dopamine Receptor Agonists
Table 12. Major Players of Safinamide Mesylate in combination with Levodopa
Table 13. Global Mesylate Safinamide Sales by Combination Therapy (2021-2026) & (Units)
Table 14. Global Mesylate Safinamide Sales Market Share by Combination Therapy (2021-2026)
Table 15. Global Mesylate Safinamide Revenue by Combination Therapy (2021-2026) & ($ million)
Table 16. Global Mesylate Safinamide Revenue Market Share by Combination Therapy (2021-2026)
Table 17. Global Mesylate Safinamide Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 18. Major Players of Oral
Table 19. Major Players of Injectable
Table 20. Global Mesylate Safinamide Sales by Dosage Form (2021-2026) & (Units)
Table 21. Global Mesylate Safinamide Sales Market Share by Dosage Form (2021-2026)
Table 22. Global Mesylate Safinamide Revenue by Dosage Form (2021-2026) & ($ million)
Table 23. Global Mesylate Safinamide Revenue Market Share by Dosage Form (2021-2026)
Table 24. Global Mesylate Safinamide Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 25. Major Players of Innovator
Table 26. Major Players of Generic
Table 27. Global Mesylate Safinamide Sales by Manufacturing Technology (2021-2026) & (Units)
Table 28. Global Mesylate Safinamide Sales Market Share by Manufacturing Technology (2021-2026)
Table 29. Global Mesylate Safinamide Revenue by Manufacturing Technology (2021-2026) & ($ million)
Table 30. Global Mesylate Safinamide Revenue Market Share by Manufacturing Technology (2021-2026)
Table 31. Global Mesylate Safinamide Sale Price by Manufacturing Technology (2021-2026) & (US$/Unit)
Table 32. Global Mesylate Safinamide Sale by Application (2021-2026) & (Units)
Table 33. Global Mesylate Safinamide Sale Market Share by Application (2021-2026)
Table 34. Global Mesylate Safinamide Revenue by Application (2021-2026) & ($ million)
Table 35. Global Mesylate Safinamide Revenue Market Share by Application (2021-2026)
Table 36. Global Mesylate Safinamide Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Mesylate Safinamide Sales by Company (2021-2026) & (Units)
Table 38. Global Mesylate Safinamide Sales Market Share by Company (2021-2026)
Table 39. Global Mesylate Safinamide Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Mesylate Safinamide Revenue Market Share by Company (2021-2026)
Table 41. Global Mesylate Safinamide Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Mesylate Safinamide Producing Area Distribution and Sales Area
Table 43. Players Mesylate Safinamide Products Offered
Table 44. Mesylate Safinamide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Mesylate Safinamide Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Mesylate Safinamide Sales Market Share Geographic Region (2021-2026)
Table 49. Global Mesylate Safinamide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Mesylate Safinamide Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Mesylate Safinamide Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Mesylate Safinamide Sales Market Share by Country/Region (2021-2026)
Table 53. Global Mesylate Safinamide Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Mesylate Safinamide Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 56. Americas Mesylate Safinamide Sales Market Share by Country (2021-2026)
Table 57. Americas Mesylate Safinamide Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 59. Americas Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 60. APAC Mesylate Safinamide Sales by Region (2021-2026) & (Units)
Table 61. APAC Mesylate Safinamide Sales Market Share by Region (2021-2026)
Table 62. APAC Mesylate Safinamide Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 64. APAC Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 65. Europe Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 66. Europe Mesylate Safinamide Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 68. Europe Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Mesylate Safinamide
Table 74. Key Market Challenges & Risks of Mesylate Safinamide
Table 75. Key Industry Trends of Mesylate Safinamide
Table 76. Mesylate Safinamide Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Mesylate Safinamide Distributors List
Table 79. Mesylate Safinamide Customer List
Table 80. Global Mesylate Safinamide Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Mesylate Safinamide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Mesylate Safinamide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Mesylate Safinamide Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Mesylate Safinamide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Mesylate Safinamide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Mesylate Safinamide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Mesylate Safinamide Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Mesylate Safinamide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Mesylate Safinamide Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Mesylate Safinamide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Zambon S.p.A. Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 95. Zambon S.p.A. Mesylate Safinamide Product Portfolios and Specifications
Table 96. Zambon S.p.A. Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Zambon S.p.A. Main Business
Table 98. Zambon S.p.A. Latest Developments
Table 99. Polpharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 100. Polpharma Mesylate Safinamide Product Portfolios and Specifications
Table 101. Polpharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Polpharma Main Business
Table 103. Polpharma Latest Developments
Table 104. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 105. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product Portfolios and Specifications
Table 106. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Biophore India Pharmaceuticals Pvt Ltd Main Business
Table 108. Biophore India Pharmaceuticals Pvt Ltd Latest Developments
Table 109. LGM Pharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 110. LGM Pharma Mesylate Safinamide Product Portfolios and Specifications
Table 111. LGM Pharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. LGM Pharma Main Business
Table 113. LGM Pharma Latest Developments
Table 114. Metrochem API Private Limited Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 115. Metrochem API Private Limited Mesylate Safinamide Product Portfolios and Specifications
Table 116. Metrochem API Private Limited Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Metrochem API Private Limited Main Business
Table 118. Metrochem API Private Limited Latest Developments
Table 119. Cohance Lifesciences Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 120. Cohance Lifesciences Mesylate Safinamide Product Portfolios and Specifications
Table 121. Cohance Lifesciences Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Cohance Lifesciences Main Business
Table 123. Cohance Lifesciences Latest Developments
Table 124. Zhejiang Hengkang Pharmaceutical Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 125. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product Portfolios and Specifications
Table 126. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Zhejiang Hengkang Pharmaceutical Main Business
Table 128. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 129. HRV Pharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 130. HRV Pharma Mesylate Safinamide Product Portfolios and Specifications
Table 131. HRV Pharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. HRV Pharma Main Business
Table 133. HRV Pharma Latest Developments
Table 134. Honour Lab Limited Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 135. Honour Lab Limited Mesylate Safinamide Product Portfolios and Specifications
Table 136. Honour Lab Limited Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Honour Lab Limited Main Business
Table 138. Honour Lab Limited Latest Developments
Table 1. Mesylate Safinamide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mesylate Safinamide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hospitals
Table 4. Major Players of Retail
Table 5. Major Players of Online
Table 6. Global Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 7. Global Mesylate Safinamide Sales Market Share by Type (2021-2026)
Table 8. Global Mesylate Safinamide Revenue by Type (2021-2026) & ($ million)
Table 9. Global Mesylate Safinamide Revenue Market Share by Type (2021-2026)
Table 10. Global Mesylate Safinamide Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Safinamide Mesylate in combination with Dopamine Receptor Agonists
Table 12. Major Players of Safinamide Mesylate in combination with Levodopa
Table 13. Global Mesylate Safinamide Sales by Combination Therapy (2021-2026) & (Units)
Table 14. Global Mesylate Safinamide Sales Market Share by Combination Therapy (2021-2026)
Table 15. Global Mesylate Safinamide Revenue by Combination Therapy (2021-2026) & ($ million)
Table 16. Global Mesylate Safinamide Revenue Market Share by Combination Therapy (2021-2026)
Table 17. Global Mesylate Safinamide Sale Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 18. Major Players of Oral
Table 19. Major Players of Injectable
Table 20. Global Mesylate Safinamide Sales by Dosage Form (2021-2026) & (Units)
Table 21. Global Mesylate Safinamide Sales Market Share by Dosage Form (2021-2026)
Table 22. Global Mesylate Safinamide Revenue by Dosage Form (2021-2026) & ($ million)
Table 23. Global Mesylate Safinamide Revenue Market Share by Dosage Form (2021-2026)
Table 24. Global Mesylate Safinamide Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 25. Major Players of Innovator
Table 26. Major Players of Generic
Table 27. Global Mesylate Safinamide Sales by Manufacturing Technology (2021-2026) & (Units)
Table 28. Global Mesylate Safinamide Sales Market Share by Manufacturing Technology (2021-2026)
Table 29. Global Mesylate Safinamide Revenue by Manufacturing Technology (2021-2026) & ($ million)
Table 30. Global Mesylate Safinamide Revenue Market Share by Manufacturing Technology (2021-2026)
Table 31. Global Mesylate Safinamide Sale Price by Manufacturing Technology (2021-2026) & (US$/Unit)
Table 32. Global Mesylate Safinamide Sale by Application (2021-2026) & (Units)
Table 33. Global Mesylate Safinamide Sale Market Share by Application (2021-2026)
Table 34. Global Mesylate Safinamide Revenue by Application (2021-2026) & ($ million)
Table 35. Global Mesylate Safinamide Revenue Market Share by Application (2021-2026)
Table 36. Global Mesylate Safinamide Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global Mesylate Safinamide Sales by Company (2021-2026) & (Units)
Table 38. Global Mesylate Safinamide Sales Market Share by Company (2021-2026)
Table 39. Global Mesylate Safinamide Revenue by Company (2021-2026) & ($ millions)
Table 40. Global Mesylate Safinamide Revenue Market Share by Company (2021-2026)
Table 41. Global Mesylate Safinamide Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers Mesylate Safinamide Producing Area Distribution and Sales Area
Table 43. Players Mesylate Safinamide Products Offered
Table 44. Mesylate Safinamide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global Mesylate Safinamide Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global Mesylate Safinamide Sales Market Share Geographic Region (2021-2026)
Table 49. Global Mesylate Safinamide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global Mesylate Safinamide Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global Mesylate Safinamide Sales by Country/Region (2021-2026) & (Units)
Table 52. Global Mesylate Safinamide Sales Market Share by Country/Region (2021-2026)
Table 53. Global Mesylate Safinamide Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global Mesylate Safinamide Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 56. Americas Mesylate Safinamide Sales Market Share by Country (2021-2026)
Table 57. Americas Mesylate Safinamide Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 59. Americas Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 60. APAC Mesylate Safinamide Sales by Region (2021-2026) & (Units)
Table 61. APAC Mesylate Safinamide Sales Market Share by Region (2021-2026)
Table 62. APAC Mesylate Safinamide Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 64. APAC Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 65. Europe Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 66. Europe Mesylate Safinamide Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 68. Europe Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa Mesylate Safinamide Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa Mesylate Safinamide Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa Mesylate Safinamide Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of Mesylate Safinamide
Table 74. Key Market Challenges & Risks of Mesylate Safinamide
Table 75. Key Industry Trends of Mesylate Safinamide
Table 76. Mesylate Safinamide Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. Mesylate Safinamide Distributors List
Table 79. Mesylate Safinamide Customer List
Table 80. Global Mesylate Safinamide Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global Mesylate Safinamide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas Mesylate Safinamide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC Mesylate Safinamide Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC Mesylate Safinamide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe Mesylate Safinamide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa Mesylate Safinamide Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa Mesylate Safinamide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global Mesylate Safinamide Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global Mesylate Safinamide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global Mesylate Safinamide Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global Mesylate Safinamide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Zambon S.p.A. Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 95. Zambon S.p.A. Mesylate Safinamide Product Portfolios and Specifications
Table 96. Zambon S.p.A. Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Zambon S.p.A. Main Business
Table 98. Zambon S.p.A. Latest Developments
Table 99. Polpharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 100. Polpharma Mesylate Safinamide Product Portfolios and Specifications
Table 101. Polpharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Polpharma Main Business
Table 103. Polpharma Latest Developments
Table 104. Biophore India Pharmaceuticals Pvt Ltd Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 105. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Product Portfolios and Specifications
Table 106. Biophore India Pharmaceuticals Pvt Ltd Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Biophore India Pharmaceuticals Pvt Ltd Main Business
Table 108. Biophore India Pharmaceuticals Pvt Ltd Latest Developments
Table 109. LGM Pharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 110. LGM Pharma Mesylate Safinamide Product Portfolios and Specifications
Table 111. LGM Pharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. LGM Pharma Main Business
Table 113. LGM Pharma Latest Developments
Table 114. Metrochem API Private Limited Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 115. Metrochem API Private Limited Mesylate Safinamide Product Portfolios and Specifications
Table 116. Metrochem API Private Limited Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Metrochem API Private Limited Main Business
Table 118. Metrochem API Private Limited Latest Developments
Table 119. Cohance Lifesciences Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 120. Cohance Lifesciences Mesylate Safinamide Product Portfolios and Specifications
Table 121. Cohance Lifesciences Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Cohance Lifesciences Main Business
Table 123. Cohance Lifesciences Latest Developments
Table 124. Zhejiang Hengkang Pharmaceutical Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 125. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Product Portfolios and Specifications
Table 126. Zhejiang Hengkang Pharmaceutical Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Zhejiang Hengkang Pharmaceutical Main Business
Table 128. Zhejiang Hengkang Pharmaceutical Latest Developments
Table 129. HRV Pharma Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 130. HRV Pharma Mesylate Safinamide Product Portfolios and Specifications
Table 131. HRV Pharma Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. HRV Pharma Main Business
Table 133. HRV Pharma Latest Developments
Table 134. Honour Lab Limited Basic Information, Mesylate Safinamide Manufacturing Base, Sales Area and Its Competitors
Table 135. Honour Lab Limited Mesylate Safinamide Product Portfolios and Specifications
Table 136. Honour Lab Limited Mesylate Safinamide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Honour Lab Limited Main Business
Table 138. Honour Lab Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mesylate Safinamide
Figure 2. Mesylate Safinamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesylate Safinamide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mesylate Safinamide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mesylate Safinamide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mesylate Safinamide Sales Market Share by Country/Region (2025)
Figure 10. Mesylate Safinamide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hospitals
Figure 12. Product Picture of Retail
Figure 13. Product Picture of Online
Figure 14. Global Mesylate Safinamide Sales Market Share by Type in 2026
Figure 15. Global Mesylate Safinamide Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Safinamide Mesylate in combination with Dopamine Receptor Agonists
Figure 17. Product Picture of Safinamide Mesylate in combination with Levodopa
Figure 18. Global Mesylate Safinamide Sales Market Share by Combination Therapy in 2026
Figure 19. Global Mesylate Safinamide Revenue Market Share by Combination Therapy (2021-2026)
Figure 20. Product Picture of Oral
Figure 21. Product Picture of Injectable
Figure 22. Global Mesylate Safinamide Sales Market Share by Dosage Form in 2026
Figure 23. Global Mesylate Safinamide Revenue Market Share by Dosage Form (2021-2026)
Figure 24. Product Picture of Innovator
Figure 25. Product Picture of Generic
Figure 26. Global Mesylate Safinamide Sales Market Share by Manufacturing Technology in 2026
Figure 27. Global Mesylate Safinamide Revenue Market Share by Manufacturing Technology (2021-2026)
Figure 28. Mesylate Safinamide Consumed in Used in combination with Levodopa
Figure 29. Global Mesylate Safinamide Market: Used in combination with Levodopa (2021-2026) & (Units)
Figure 30. Mesylate Safinamide Consumed in Treatment of Levodopa-resistant Parkinson's Disease
Figure 31. Global Mesylate Safinamide Market: Treatment of Levodopa-resistant Parkinson's Disease (2021-2026) & (Units)
Figure 32. Mesylate Safinamide Consumed in Others
Figure 33. Global Mesylate Safinamide Market: Others (2021-2026) & (Units)
Figure 34. Global Mesylate Safinamide Sale Market Share by Application (2025)
Figure 35. Global Mesylate Safinamide Revenue Market Share by Application in 2025
Figure 36. Mesylate Safinamide Sales by Company in 2025 (Units)
Figure 37. Global Mesylate Safinamide Sales Market Share by Company in 2025
Figure 38. Mesylate Safinamide Revenue by Company in 2025 ($ millions)
Figure 39. Global Mesylate Safinamide Revenue Market Share by Company in 2025
Figure 40. Global Mesylate Safinamide Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Mesylate Safinamide Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Mesylate Safinamide Sales 2021-2026 (Units)
Figure 43. Americas Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 44. APAC Mesylate Safinamide Sales 2021-2026 (Units)
Figure 45. APAC Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 46. Europe Mesylate Safinamide Sales 2021-2026 (Units)
Figure 47. Europe Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Mesylate Safinamide Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 50. Americas Mesylate Safinamide Sales Market Share by Country in 2025
Figure 51. Americas Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Figure 52. Americas Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 53. Americas Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 54. United States Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Mesylate Safinamide Sales Market Share by Region in 2025
Figure 59. APAC Mesylate Safinamide Revenue Market Share by Region (2021-2026)
Figure 60. APAC Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 61. APAC Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 62. China Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 66. India Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Mesylate Safinamide Sales Market Share by Country in 2025
Figure 70. Europe Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Figure 71. Europe Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 72. Europe Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 73. Germany Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 74. France Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Mesylate Safinamide Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 81. Egypt Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Mesylate Safinamide in 2026
Figure 87. Manufacturing Process Analysis of Mesylate Safinamide
Figure 88. Industry Chain Structure of Mesylate Safinamide
Figure 89. Channels of Distribution
Figure 90. Global Mesylate Safinamide Sales Market Forecast by Region (2027-2032)
Figure 91. Global Mesylate Safinamide Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Mesylate Safinamide Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Mesylate Safinamide Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Mesylate Safinamide Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Mesylate Safinamide Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Mesylate Safinamide
Figure 2. Mesylate Safinamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesylate Safinamide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mesylate Safinamide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mesylate Safinamide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mesylate Safinamide Sales Market Share by Country/Region (2025)
Figure 10. Mesylate Safinamide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hospitals
Figure 12. Product Picture of Retail
Figure 13. Product Picture of Online
Figure 14. Global Mesylate Safinamide Sales Market Share by Type in 2026
Figure 15. Global Mesylate Safinamide Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Safinamide Mesylate in combination with Dopamine Receptor Agonists
Figure 17. Product Picture of Safinamide Mesylate in combination with Levodopa
Figure 18. Global Mesylate Safinamide Sales Market Share by Combination Therapy in 2026
Figure 19. Global Mesylate Safinamide Revenue Market Share by Combination Therapy (2021-2026)
Figure 20. Product Picture of Oral
Figure 21. Product Picture of Injectable
Figure 22. Global Mesylate Safinamide Sales Market Share by Dosage Form in 2026
Figure 23. Global Mesylate Safinamide Revenue Market Share by Dosage Form (2021-2026)
Figure 24. Product Picture of Innovator
Figure 25. Product Picture of Generic
Figure 26. Global Mesylate Safinamide Sales Market Share by Manufacturing Technology in 2026
Figure 27. Global Mesylate Safinamide Revenue Market Share by Manufacturing Technology (2021-2026)
Figure 28. Mesylate Safinamide Consumed in Used in combination with Levodopa
Figure 29. Global Mesylate Safinamide Market: Used in combination with Levodopa (2021-2026) & (Units)
Figure 30. Mesylate Safinamide Consumed in Treatment of Levodopa-resistant Parkinson's Disease
Figure 31. Global Mesylate Safinamide Market: Treatment of Levodopa-resistant Parkinson's Disease (2021-2026) & (Units)
Figure 32. Mesylate Safinamide Consumed in Others
Figure 33. Global Mesylate Safinamide Market: Others (2021-2026) & (Units)
Figure 34. Global Mesylate Safinamide Sale Market Share by Application (2025)
Figure 35. Global Mesylate Safinamide Revenue Market Share by Application in 2025
Figure 36. Mesylate Safinamide Sales by Company in 2025 (Units)
Figure 37. Global Mesylate Safinamide Sales Market Share by Company in 2025
Figure 38. Mesylate Safinamide Revenue by Company in 2025 ($ millions)
Figure 39. Global Mesylate Safinamide Revenue Market Share by Company in 2025
Figure 40. Global Mesylate Safinamide Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Mesylate Safinamide Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Mesylate Safinamide Sales 2021-2026 (Units)
Figure 43. Americas Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 44. APAC Mesylate Safinamide Sales 2021-2026 (Units)
Figure 45. APAC Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 46. Europe Mesylate Safinamide Sales 2021-2026 (Units)
Figure 47. Europe Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Mesylate Safinamide Sales 2021-2026 (Units)
Figure 49. Middle East & Africa Mesylate Safinamide Revenue 2021-2026 ($ millions)
Figure 50. Americas Mesylate Safinamide Sales Market Share by Country in 2025
Figure 51. Americas Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Figure 52. Americas Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 53. Americas Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 54. United States Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Mesylate Safinamide Sales Market Share by Region in 2025
Figure 59. APAC Mesylate Safinamide Revenue Market Share by Region (2021-2026)
Figure 60. APAC Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 61. APAC Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 62. China Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 66. India Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Mesylate Safinamide Sales Market Share by Country in 2025
Figure 70. Europe Mesylate Safinamide Revenue Market Share by Country (2021-2026)
Figure 71. Europe Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 72. Europe Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 73. Germany Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 74. France Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Mesylate Safinamide Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Mesylate Safinamide Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Mesylate Safinamide Sales Market Share by Application (2021-2026)
Figure 81. Egypt Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Mesylate Safinamide Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Mesylate Safinamide in 2026
Figure 87. Manufacturing Process Analysis of Mesylate Safinamide
Figure 88. Industry Chain Structure of Mesylate Safinamide
Figure 89. Channels of Distribution
Figure 90. Global Mesylate Safinamide Sales Market Forecast by Region (2027-2032)
Figure 91. Global Mesylate Safinamide Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Mesylate Safinamide Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Mesylate Safinamide Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Mesylate Safinamide Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Mesylate Safinamide Revenue Market Share Forecast by Application (2027-2032)
